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background: Current guidelines discourage percutaneous coronary intervention (PCI) of non-infarct-related arteries at the time of primary PCI in 
patients with ST-elevation myocardial infarction (STEMI) without cardiogenic shock. The optimal strategy for treating non-culprit disease is currently 
under debate.
methods: We conducted an observational analysis comparing culprit vessel intervention (CVI) versus multivessel intervention (MVI) in patients 
who had primary PCI between 2004-2011 at all 8 tertiary cardiac centres in London. Patients with cardiogenic shock and bystander left main-stem 
disease (>50% stenosis) were excluded. Cox proportional hazard models were built to determine independent predictors for all-cause mortality. A 
propensity-matched analysis was performed on patients with multivessel disease (defined as stenosis >50% in ≥2 epicardial coronary arteries).
results: Of the 9377 patients included in the analysis, 8755 patients (93%) had CVI and 622 patients (7%) had MVI. CVI was as an independent 
predictor for survival at 1 year in the full patient cohort (HR=0.61, 95% CI:0.45-0.82, p=0.001); in 3984 patients with multivessel disease 
(HR=0.65, 95% CI:0.47-0.91, p=0.011); and in 734 patients in propensity-matched cohorts (HR=0.52, 95% CI:0.23-0.95, p=0.034).
Conclusions: In this observational analysis of patients with STEMI undergoing primary PCI, CVI was independently associated with reduced 1-year 
mortality. Our findings support current recommended practice guidelines.
 
